Genmab offers $1.8bn for ADC specialist ProfoundBio April 3, 2024 AutoBot News 0 Antibody developer Genmab has made a play to boost its expertise in the scalding hot area of antibody-drug conjugates (ADCs), agreeing a $1.8 billion deal to acquire ProfoundBio.